R&D
Research & Development
Kolon Pharmaceuticals is dedicated to innovating and creating value through relentless research and development.
Pipeline
| Classification | CODE | Targeted Indication | Development Phase | ||||
|---|---|---|---|---|---|---|---|
| Exploratory studies | Preclinical trials | Clinical trials | Authorization | Launch | |||
| Advanced New Medications | KP-2303 | Atopic dermatitis | |||||
| KP-1508 | IPF | ||||||
| Health Functional Foods | |||||||
| Natural functional components | Musculoskeletal disorders | ||||||
License-In
| Category | Brand (Molecule) |
Targeted Indication |
Development Schedule | |||||
|---|---|---|---|---|---|---|---|---|
| PC | Ph. Ⅰ | Ph. Ⅱ | Ph. Ⅲ | NDA | P&R | |||
| License-In | Bilaxten® (Bilastine) | Anti-histamine | ||||||
| NELCLEAR® (Terbinafine) | Onychomycosis | |||||||
| Trimbow® (Beclomethasone + Formoterol +Glycopyrronium) | COPD / Asthma | |||||||
